Download PDF

Published: 31 October 2013


In issue 93:

  • Macitentan for PAH
  • Riociguat for PAH
  • Riociguat for CTEPH
  • Death in PAH
  • Pulmonary hypertension referrals to tertiary centres
  • Sildenafil for respiratory outcomes in COPD
  • Edoxaban vs. warfarin for symptomatic VTE
  • Apixaban for extended VTE treatment
  • Dabigatran dosing and renal function/drug interactions
  • Out- vs. inpatient PE treatment
  • Delayed presentation of suspected PE
  • DVT/PE risk in asthma